Literature DB >> 11112664

Gene preference in maple syrup urine disease.

M M Nellis1, D J Danner.   

Abstract

Untreated maple syrup urine disease (MSUD) results in mental and physical disabilities and often leads to neonatal death. Newborn-screening programs, coupled with the use of protein-modified diets, have minimized the severity of this phenotype and allowed affected individuals to develop into productive adults. Although inheritance of MSUD adheres to rules for single-gene traits, mutations in the genes for E1alpha, E1beta, or E2 of the mitochondrial branched-chain alpha-ketoacid dehydrogenase complex can cause the disease. Randomly selected cell lines from 63 individuals with clinically diagnosed MSUD were tested by retroviral complementation of branched-chain alpha-ketoacid dehydrogenase activity to identify the gene locus for mutant alleles. The frequencies of the mutations were 33% for the E1alpha gene, 38% for the E1beta gene, and 19% for the E2 gene. Ten percent of the tested cell lines gave ambiguous results by showing no complementation or restoration of activity with two gene products. These results provide a means to establish a genotype/phenotype relationship in MSUD, with the ultimate goal of unraveling the complexity of this single-gene trait. This represents the largest study to date providing information on the genotype for MSUD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11112664      PMCID: PMC1234918          DOI: 10.1086/316950

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  19 in total

1.  Thiamine increases the specific activity of human liver branched chain alpha-ketoacid dehydrogenase.

Authors:  D J Danner; E D Davidson; L J Elsas
Journal:  Nature       Date:  1975-04-10       Impact factor: 49.962

Review 2.  The 2-oxo acid dehydrogenase complexes: recent advances.

Authors:  S J Yeaman
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

Review 3.  Structure-function relationships in dihydrolipoamide acyltransferases.

Authors:  L J Reed; M L Hackert
Journal:  J Biol Chem       Date:  1990-06-05       Impact factor: 5.157

4.  Construction and nucleotide sequence of a cDNA encoding the full-length preprotein for human branched chain acyltransferase.

Authors:  D J Danner; S Litwer; W J Herring; J Pruckler
Journal:  J Biol Chem       Date:  1989-05-05       Impact factor: 5.157

5.  Activity state of the branched chain alpha-ketoacid dehydrogenase complex in heart, liver, and kidney of normal, fasted, diabetic, and protein-starved rats.

Authors:  S E Gillim; R Paxton; G A Cook; R A Harris
Journal:  Biochem Biophys Res Commun       Date:  1983-02-28       Impact factor: 3.575

6.  Branched chain acyltransferase absence due to an Alu-based genomic deletion allele and an exon skipping allele in a compound heterozygote proband expressing maple syrup urine disease.

Authors:  W J Herring; M McKean; N Dracopoli; D J Danner
Journal:  Biochim Biophys Acta       Date:  1992-03-20

7.  Thiamine response in maple syrup urine disease.

Authors:  P M Fernhoff; D Lubitz; D J Danner; P P Dembure; H P Schwartz; R Hillman; D M Bier; L J Elsas
Journal:  Pediatr Res       Date:  1985-10       Impact factor: 3.756

8.  Thiamin-responsive maple syrup urine disease in a patient antigenically missing dihydrolipoamide acyltransferase.

Authors:  N P Ellerine; W J Herring; L J Elsas; M C McKean; P D Klein; D J Danner
Journal:  Biochem Med Metab Biol       Date:  1993-06

9.  Absence of branched chain acyl-transferase as a cause of maple syrup urine disease.

Authors:  D J Danner; N Armstrong; S C Heffelfinger; E T Sewell; J H Priest; L J Elsas
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

10.  Reversion of the maple syrup urine disease phenotype of impaired branched chain alpha-ketoacid dehydrogenase complex activity in fibroblasts from an affected child.

Authors:  S Litwer; W J Herring; D J Danner
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.157

View more
  17 in total

1.  Molecular architecture and mechanism of an icosahedral pyruvate dehydrogenase complex: a multifunctional catalytic machine.

Authors:  Jacqueline L S Milne; Dan Shi; Peter B Rosenthal; Joshua S Sunshine; Gonzalo J Domingo; Xiongwu Wu; Bernard R Brooks; Richard N Perham; Richard Henderson; Sriram Subramaniam
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

2.  Functional characterization of the novel intronic nucleotide change c.288+9C>T within the BCKDHA gene: understanding a variant presentation of maple syrup urine disease.

Authors:  Paula Fernández-Guerra; Rosa Navarrete; Kara Weisiger; Lourdes R Desviat; Seymour Packman; Magdalena Ugarte; Pilar Rodríguez-Pombo
Journal:  J Inherit Metab Dis       Date:  2010-04-30       Impact factor: 4.982

3.  Variant maple syrup urine disease (MSUD)--the entire spectrum.

Authors:  E Simon; N Flaschker; P Schadewaldt; U Langenbeck; U Wendel
Journal:  J Inherit Metab Dis       Date:  2006-10-25       Impact factor: 4.982

4.  Maple syrup urine disease: identification and carrier-frequency determination of a novel founder mutation in the Ashkenazi Jewish population.

Authors:  L Edelmann; M P Wasserstein; R Kornreich; C Sansaricq; S E Snyderman; G A Diaz
Journal:  Am J Hum Genet       Date:  2001-08-16       Impact factor: 11.025

5.  Successful domino liver transplantation in maple syrup urine disease using a related living donor.

Authors:  F H Feier; I K Miura; E A Fonseca; G Porta; R Pugliese; A Porta; I V D Schwartz; A V B Margutti; J S Camelo; S N Yamaguchi; A T Taveira; H Candido; M Benavides; V Danesi; T Guimaraes; M Kondo; P Chapchap; J Seda Neto
Journal:  Braz J Med Biol Res       Date:  2014-04-25       Impact factor: 2.590

6.  Mutations in the gene for the E1beta subunit: a novel cause of pyruvate dehydrogenase deficiency.

Authors:  Ruth M Brown; Rosemary A Head; Ivan I Boubriak; James V Leonard; Neil H Thomas; Garry K Brown
Journal:  Hum Genet       Date:  2004-05-11       Impact factor: 4.132

7.  Description of the mutations in 15 subjects with variant forms of maple syrup urine disease.

Authors:  N Flaschker; O Feyen; S Fend; E Simon; P Schadewaldt; U Wendel
Journal:  J Inherit Metab Dis       Date:  2007-10-08       Impact factor: 4.982

8.  Administration of branched-chain amino acids alters epigenetic regulatory enzymes in an animal model of Maple Syrup Urine Disease.

Authors:  Emilio L Streck; Felipe P Bussular; Leticia B Wessler; Mariane B Duarte; Victoria L Rezende; Matheus S Rodrigues; Carolina A Torres; Isabela S Lemos; Gabriela Candiotto; Fernanda F Gava; Jade de Oliveira; Samira S Valvassori
Journal:  Metab Brain Dis       Date:  2020-10-24       Impact factor: 3.584

9.  Maple syrup urine disease: mutation analysis in Turkish patients.

Authors:  A Dursun; M Henneke; K Ozgül; J Gartner; T Coşkun; A Tokatli; H S Kalkanoğlu; M Demirkol; U Wendel; I Ozalp
Journal:  J Inherit Metab Dis       Date:  2002-05       Impact factor: 4.982

10.  Prenatal diagnosis of a novel mutation, c.529C>T (p.Q177X), in the BCKDHA gene in a family with maple syrup urine disease.

Authors:  R Tammachote; S Tongkobpetch; T Desudchit; K Suphapeetiporn; V Shotelersuk
Journal:  J Inherit Metab Dis       Date:  2009-02-24       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.